Probiotic (VSL#3) for Gulf War Illness

Abstract

The overall objective of the study is to determine whether probiotic VSL#3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War illness. The project was approved by Human Research Protection Office, Department of Defense in August 2013. We received the drug shipment from the manufacturer of VSL#3 in September 2013. We are in contact with the Lawrence Berkeley Laboratories to arrange for shipment of stool samples and microflora analysis. We screened our first participant in September 2013.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2013
Accession Number
ADA589725

Entities

People

  • Ashok K Tuteja

Organizations

  • Western Institute For Biomedical Research

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Buildings And Structures
  • Colonic Diseases
  • Department Of Defense
  • Digestive System Diseases
  • Diseases And Disorders
  • Electronic Mail
  • Gastrointestinal Diseases
  • Gut Microbiome
  • Health Services
  • Information Operations
  • Insomnia
  • Institutional Review Board
  • Pain
  • Persian Gulf Syndrome
  • Stiffness
  • United States

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Systems Analysis and Design